Earlier last week, Politico leaked a chapter from a recent draft of the Trans-Pacific Partnership (TPP) free-trade agreement granting intellectual property protection for pharmaceutical drugs. Unfortunately, for trade negotiators, the leaked information does little to quell the loud harangues and controversy surrounding international intellectual property rights (IPR). Developing countries and proponents for the global poor, labor unions, … Continue reading →